search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Protection after yellow fever vaccination in patients using medication suppressing the immune system.


- candidate number13239
- NTR NumberNTR3581
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR16-aug-2012
- Secondary IDsNL40560.018.12 CCMO
- Public TitleProtection after yellow fever vaccination in patients using medication suppressing the immune system.
- Scientific TitleImmunity after yellow fever vaccination in travelers using immunosuppressive medication.
- ACRONYMYETI study
- hypothesisYellow fever specific T cells are present in 70% of patients using immunosuppressive medication versus 99% of healthy volunteers.
- Healt Condition(s) or Problem(s) studiedYellow fever vaccination
- Inclusion criteria1. Age > 18 years;
2. YF 17D vaccination administered.
- Exclusion criteria1. Age < 18 years;
2. Vaccination administered > 20 years ago.
- mec approval receivedyes
- multicenter trialyes
- randomisedno
- groupParallel
- TypeSingle arm
- Studytypeobservational
- planned startdate 14-aug-2012
- planned closingdate14-aug-2013
- Target number of participants60
- Interventions1. Administration of a questionnaire about adverse events following vaccination;
2. Venapunction (54 mL) on 1 day.
- Primary outcomeProportion of those with CD8 positive T cells in the group using immunosuppressive medication versus healthy controls.
- Secondary outcomeProportion of those with Virus Neutralising antibody present in the group using immunosuppressive medication versus healthy controls.
Proportion of those with local adverse events n the group using immunosuppressive medication versus healthy controls.
- TimepointsN/A
- Trial web siteN/A
- statusplanned
- CONTACT FOR PUBLIC QUERIES M.P. Grobusch
- CONTACT for SCIENTIFIC QUERIES A. Goorhuis
- Sponsor/Initiator Academic Medical Center (AMC), Amsterdam
- Funding
(Source(s) of Monetary or Material Support)
Academic Medical Center (AMC)
- PublicationsN/A
- Brief summaryRationale:
The immune response following yellow fever vaccinations may be suboptimal in those using immunosuppressive medication. Possibly, this population has a less durable and lower immunologic memory response compared to healthy controls, and more frequent revaccination might be required in this group.

Objective:
Our main objective is to compare duration and height of immune memory in vaccinees who were using immunosuppressive medication at the time of vaccination to health vaccinees. Our secondary outcome measures are antibodies present and adverse events in both groups.

Study design:
Retrospective observational study.

Study population:
Patients using immunosuppressive medication vaccinated with the yellow fever vaccine maximum 20 years ago, aged > 18 years shall be included. Healthy controls matched by age, sex and time after vaccination shall be included as well.

Main study parameters/endpoints:
The main endpoint is the proportion of those with immunologic memory in the patient group compared to the control group.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness:
Participants shall be asked to fill in one questionnaire on adverse events and a venapunction shall be performed at one clinical visit. Risks are bruising and pain of the arm (both expected to be mild and transient). Benefits for participants are increased insight in their immunologic response and the awareness of protection against the yellow fever virus.
- Main changes (audit trail)
- RECORD16-aug-2012 - 8-sep-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl